Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Evaluation of the clinical safety and efficacy of loteprednol etabonate in an ophthalmic
base, when compared to vehicle for the treatment of inflammation following cataract surgery.